CPBTD
TEVA icon

Central Pacific Bank - Trust Division’s Teva Pharmaceuticals TEVA Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-54,275
Closed -$910K – 856
2025
Q2 		$910K Buy
54,275
+1,245
+2% +$20.1K 0.12% 186
2025
Q1 		$815K Buy
53,030
+10,603
+25% +$189K 0.11% 183
2024
Q4 		$935K Buy
+42,427
New +$772K 0.12% 176

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Central Pacific Bank - Trust Division's TEVA Position: Q3 2025 in Review

Central Pacific Bank - Trust Division sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 54,275 shares — an estimated $910K sold.

Central Pacific Bank - Trust Division first reported a position in TEVA in Q4 2024 and held it in 3 quarters. The position peaked at $935K in Q4 2024. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Central Pacific Bank - Trust Division reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 54,275 Teva Pharmaceuticals shares in Q3 2025, an estimated $910K.
  • Central Pacific Bank - Trust Division first reported a position in Teva Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Central Pacific Bank - Trust Division's Teva Pharmaceuticals position peaked at $935K in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2025, filed 2 Oct 2025.